| 臺大學術典藏 |
2021-05-02T03:49:09Z |
Assessing tumor angiogenesis using dynamic contrast-enhanced integrated magnetic resonance-positron emission tomography in patients with non-small-cell lung cancer
|
Huang Y.-S.; Chen J.L.-Y.; Chen H.-M.; Yeh L.-H.; JIN-YUAN SHIH; Yen R.-F.; Chang Y.-C. |
| 臺大學術典藏 |
2021-04-21T23:30:40Z |
Cell metabolomics analyses revealed a role of altered fatty acid oxidation in neurotoxicity pattern difference between nab-paclitaxel and solvent-based paclitaxel
|
Huang, Jhih Wei; CHING-HUA KUO; Kuo, Han Chun; JIN-YUAN SHIH; Tsai, Teng Wen; LIN-CHAU CHANG |
| 臺大學術典藏 |
2021-03-11T08:34:21Z |
Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma
|
Liang S.-K.;Hsieh M.-S.;Lee M.-R.;Keng L.-T.;Jen-Chang Ko;Shih J.-Y.; SHENG-KAI LIANG; Min-Shu Hsieh; MENG-RUI LEE; LI-TA KENG; JEN-CHANG KO; Jin-Yuan Shih |
| 臺大學術典藏 |
2021-03-11T08:34:18Z |
Afatinib is effective in the treatment of lung adenocarcinoma with uncommon EGFR p.L747P and p.L747S mutations
|
Liang S.-K.;Jen-Chang Ko;Yang J.C.-H.;Shih J.-Y.; SHENG-KAI LIANG; JEN-CHANG KO; James Chih-Hsin Yang; Jin-Yuan Shih |
| 臺大學術典藏 |
2021-02-08T08:05:08Z |
Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort
|
Jen-Chung Ko;Sheng-Kai Liang;Li-Ta Keng;Chia-Hao Chang;Yueh-Feng Wen ; Meng-Rui Lee ; Ching-Yao Yang ; Jann-Yuan Wang ; Jin-Yuan Shih ; Chong-Jen Yu; JEN-CHUNG KO; SHENG-KAI LIANG; LI-TA KENG; CHIA-HAO CHANG; Yueh-Feng Wen ; Meng-Rui Lee ; Ching-Yao Yang ; Jann-Yuan Wang ; Jin-Yuan Shih ; Chong-Jen Yu |
| 臺大學術典藏 |
2021-02-02T09:21:39Z |
Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort
|
SHENG-KAI LIANG; LI-TA KENG; CHIA-HAO CHANG; Wen, Yueh Feng; MENG-RUI LEE; Yang, Ching Yao; JANN-YUAN WANG; JEN-CHUNG KO; JIN-YUAN SHIH; CHONG-JEN YU |
| 臺大學術典藏 |
2021-01-18T09:12:07Z |
Ramucirumab or placebo plus erlotinib in EGFR-mutated, metastatic non-small-cell lung cancer: East Asian subset of RELAY
|
Nishio, Makoto; Seto, Takashi; Reck, Martin; Garon, Edward B.; Chiu, Chao Hua; Yoh, Kiyotaka; Imamura, Fumio; Park, Keunchil; JIN-YUAN SHIH; Visseren-Grul, Carla; Frimodt-Moller, Bente; Zimmermann, Annamaria; Homma, Gosuke; Enatsu, Sotaro; Nakagawa, Kazuhiko |
| 臺大學術典藏 |
2021-01-08T02:56:46Z |
Significant clinical factors associated with long-term mortality in critical cancer patients requiring prolonged mechanical ventilation
|
Yen-Fu Chen; I-Chun Chen; Jui-Chen Cheng; SHENG-KAI LIANG; Shu-Yung Lin; Li-Ta Keng;Chung K.-P.;Lin S.-Y.;Liang S.-K.;Cheng J.-C.;Chen I.-C.;Chen Y.-F.;Chang H.-T.;Hsu C.-L.;Jerng J.-S.;Wang H.-C.;Kuo P.-H.;Wu H.-D.;Shih J.-Y.;Yu C.-J.; LI-TA KENG; Kuei-Pin Chung; Hou-Tai Chang; Chia-Lin Hsu; Jih-Shuin Jerng; Hao-Chien Wang; Ping-Hung Kuo; Huey-Dong Wu; Jin-Yuan Shih; Chong-Jen Yu |
| 臺大學術典藏 |
2020-08-13T06:34:14Z |
Elevated serum levels of mucin-associated antigen in patients with acute respiratory distress syndrome
|
Jin-Yuan Shih;Yang S.-C.;Yu C.-J.;Wu H.-D.;Liaw Y.-S.;Wu R.;Yang P.-C.; JIN-YUAN SHIH; Yang S.-C.; Yu C.-J.; Wu H.-D.; Liaw Y.-S.; Wu R.; Yang P.-C. |
| 臺大學術典藏 |
2020-08-13T06:34:14Z |
Echogenic floating spherules as a sonographic sign of cystic teratoma of mediastinum: Correlation with CT and pathologic findings
|
Wang H.-C.; JIN-YUAN SHIH; Jin-Yuan Shih;Wang H.-C.;Chang Y.-L.;Chang Y.-C.;Lee Y.-C.;Yang P.-C.; Chang Y.-L.; Chang Y.-C.; Lee Y.-C.; Yang P.-C. |
| 臺大學術典藏 |
2020-08-13T06:34:13Z |
Nontuberculous mycobacteria isolates: Clinical significance and disease spectrum
|
Wang H.-C.; Lee L.-N.; Hsueh P.-R.; JIN-YUAN SHIH; Jin-Yuan Shih;Hsueh P.-R.;Lee L.-N.;Wang H.-C.;Yang P.-C.;Kuo S.-H.;Luh K.-T.; Yang P.-C.; Kuo S.-H.; Luh K.-T. |
| 臺大學術典藏 |
2020-08-13T06:34:11Z |
New aspects in clinicopathologic and oncogene studies of 23 pulmonary lymphoepithelioma-like carcinomas
|
Lee Y.-C.; JIN-YUAN SHIH; Wu C.-T.; Chang Y.-L.; Chang Y.-L.;Wu C.-T.;Jin-Yuan Shih;Lee Y.-C. |
| 臺大學術典藏 |
2020-08-13T06:34:11Z |
Collapsin response mediator protein-1 and the invasion and metastasis of cancer cells
|
Jin-Yuan Shih;Yang S.-C.;Hong T.-M.;Yuan A.;Chen J.J.W.;Yu C.-J.;Chang Y.-L.;Lee Y.-C.;Peck K.;Wu C.-W.;Yang P.-C.; JIN-YUAN SHIH; Yang S.-C.; Hong T.-M.; Yuan A.; Chen J.J.W.; Yu C.-J.; Chang Y.-L.; Lee Y.-C.; Peck K.; Wu C.-W.; Yang P.-C. |
| 臺大學術典藏 |
2020-08-13T06:34:10Z |
Tumor-associated antigen L6 and the invasion of human lung cancer cells
|
Chu Y.-W.; Yang P.-C.; Wu C.-W.; Roffler S.R.; Kao Y.-R.;Jin-Yuan Shih;Wen W.-C.;Ko Y.-P.;Chen B.-M.;Chan Y.-L.;Chu Y.-W.;Yang P.-C.;Wu C.-W.;Roffler S.R.; Chan Y.-L.; Chen B.-M.; Ko Y.-P.; Wen W.-C.; JIN-YUAN SHIH; Kao Y.-R. |
| 臺大學術典藏 |
2020-08-13T06:34:10Z |
Collapsin response mediator protein-1: A novel invasion-suppressor gene
|
Lee Y.-C.G.; Yang S.-C.; Hong T.-M.; Huang C.-Y.F.; Yang P.-C.; JIN-YUAN SHIH; Jin-Yuan Shih;Lee Y.-C.G.;Yang S.-C.;Hong T.-M.;Huang C.-Y.F.;Yang P.-C. |
| 臺大學術典藏 |
2020-08-13T06:34:10Z |
Tuberculous myositis: A rare but existing clinical entity
|
JIN-YUAN SHIH; Chang Y.L.; Yang P.C.; Luh K.T.; Hsueh P.R.; Lee L.N.; Wang J.Y.; Wang J.Y.;Lee L.N.;Hsueh P.R.;Jin-Yuan Shih;Chang Y.L.;Yang P.C.;Luh K.T. |
| 臺大學術典藏 |
2020-08-13T06:34:10Z |
Small-cell lung cancer presenting with Lambert-Eaton myasthenic syndrome and respiratory failure
|
Yang P.-C.; Yu C.-J.; Wu R.-M.; Wang H.-C.; JIN-YUAN SHIH; Jiang J.-R.; Jiang J.-R.;Jin-Yuan Shih;Wang H.-C.;Wu R.-M.;Yu C.-J.;Yang P.-C. |
| 臺大學術典藏 |
2020-08-13T06:34:09Z |
Cyclooxygenase-2-Induces EP1- and HER-2/Neu-Dependent Vascular, Endothelial Growth Factor-C Up-Regulation: A Novel Mechanism of Lymphangiogenesis in Lung Adenocarcinoma
|
Su J.-L.;Jin-Yuan Shih;Yen M.-L.;Jeng Y.-M.;Chang C.-C.;Hsieh C.-Y.;Wei L.-H.;Yang P.-C.;Kuo M.-L.; Su J.-L.; JIN-YUAN SHIH; Yen M.-L.; Jeng Y.-M.; Chang C.-C.; Hsieh C.-Y.; Wei L.-H.; Yang P.-C.; Kuo M.-L. |
| 臺大學術典藏 |
2020-08-13T06:34:08Z |
Sialyl Lewis antigens: Association with MUC5AC protein and correlation with post-operative recurrence of non-small cell lung cancer
|
Yu C.-J.;Jin-Yuan Shih;Lee Y.-C.;Shun C.-T.;Yuan A.;Yang P.-C.; Yu C.-J.; JIN-YUAN SHIH; Lee Y.-C.; Shun C.-T.; Yuan A.; Yang P.-C. |
| 臺大學術典藏 |
2020-08-13T06:34:08Z |
Prognosis of non-small cell lung cancer patients by detecting circulating cancer cells in the peripheral blood with multiple marker genes
|
Sher Y.-P.;Jin-Yuan Shih;Yang P.-C.;Roffler S.R.;Chu Y.-W.;Wu C.-W.;Yu C.-L.;Peck K.; Sher Y.-P.; JIN-YUAN SHIH; Yang P.-C.; Roffler S.R.; Chu Y.-W.; Wu C.-W.; Yu C.-L.; Peck K. |
| 臺大學術典藏 |
2020-08-13T06:34:08Z |
Frequent allelic deletion at the FHIT locus associated with p53 overexpression in squamous cell carcinoma subtype of Taiwanese non-small-cell lung cancers
|
JIN-YUAN SHIH; Wu C.-T.; Lee Y.-C.; Lee Y.-C.;Wu C.-T.;Jin-Yuan Shih;Jou Y.-S.;Chang Y.-L.; Jou Y.-S.; Chang Y.-L. |
| 臺大學術典藏 |
2020-08-13T06:34:07Z |
The significance of estrogen receptor β in 301 surgically treated non-small cell lung cancers
|
Wu C.-T.;Chang Y.-L.;Jin-Yuan Shih;Lee Y.-C.; Wu C.-T.; Chang Y.-L.; JIN-YUAN SHIH; Lee Y.-C. |
| 臺大學術典藏 |
2020-08-13T06:34:07Z |
EGFR mutation conferring primary resistance to gefitinib in non-small-cell lung cancer [2] (multiple letters)
|
Jin-Yuan Shih;Gow C.-H.;Yang P.-C.; JIN-YUAN SHIH; Gow C.-H.; Yang P.-C. |
| 臺大學術典藏 |
2020-08-13T06:34:07Z |
Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway
|
Lo H.-W.;Hsu S.-C.;Ali-Seyed M.;Gunduz M.;Xia W.;Wei Y.;Bartholomeusz G.;Jin-Yuan Shih;Hung M.-C.; Lo H.-W.; Hsu S.-C.; Ali-Seyed M.; Gunduz M.; Xia W.; Wei Y.; Bartholomeusz G.; JIN-YUAN SHIH; Hung M.-C. |
| 臺大學術典藏 |
2020-08-13T06:34:06Z |
Epidermal growth factor receptor mutations in needle biopsy/aspiration samples predict response to gefitinib therapy and survival of patients with advanced nonsmall cell lung cancer
|
JIN-YUAN SHIH; Gow C.-H.; Yu C.-J.; Yang C.-H.; Chang Y.-L.; Tsai M.-F.; Hsu Y.-C.; Chen K.-Y.; Su W.-P.; Yang P.-C. |
